Business Description
PYC Therapeutics Ltd
ISIN : AU000000PYC7
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 60.09 | |||||
Equity-to-Asset | 0.88 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.03 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -32.6 | |||||
3-Year EPS without NRI Growth Rate | -32.6 | |||||
3-Year FCF Growth Rate | -58.7 | |||||
3-Year Book Growth Rate | -3.9 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 76.16 | |||||
9-Day RSI | 68.09 | |||||
14-Day RSI | 64.37 | |||||
6-1 Month Momentum % | 36.22 | |||||
12-1 Month Momentum % | 83.19 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 9.4 | |||||
Quick Ratio | 9.4 | |||||
Cash Ratio | 7.34 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5 | |||||
Shareholder Yield % | -17.09 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -81.92 | |||||
ROA % | -67.3 | |||||
ROIC % | -482.33 | |||||
3-Year ROIIC % | -423.91 | |||||
ROC (Joel Greenblatt) % | -2535.15 | |||||
ROCE % | -80.4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 8.52 | |||||
Price-to-Tangible-Book | 7.25 | |||||
EV-to-EBIT | -16.05 | |||||
EV-to-Forward-EBIT | -9.94 | |||||
EV-to-EBITDA | -16.31 | |||||
EV-to-Forward-EBITDA | -9.94 | |||||
EV-to-Forward-Revenue | 36.06 | |||||
EV-to-FCF | -12.11 | |||||
Price-to-Net-Current-Asset-Value | 7.25 | |||||
Price-to-Net-Cash | 14.5 | |||||
Earnings Yield (Greenblatt) % | -6.23 | |||||
FCF Yield % | -5.76 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
PYC Therapeutics Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | |||
EPS (TTM) (A$) | -0.01 | ||
Beta | 0.74 | ||
Volatility % | 90.15 | ||
14-Day RSI | 64.37 | ||
14-Day ATR (A$) | 0.011278 | ||
20-Day SMA (A$) | 0.12275 | ||
12-1 Month Momentum % | 83.19 | ||
52-Week Range (A$) | 0.051388 - 0.145 | ||
Shares Outstanding (Mil) | 4,666.08 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
PYC Therapeutics Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
PYC Therapeutics Ltd Stock Events
Event | Date | Price(A$) | ||
---|---|---|---|---|
No Event Data |
PYC Therapeutics Ltd Frequently Asked Questions
What is PYC Therapeutics Ltd(ASX:PYC)'s stock price today?
When is next earnings date of PYC Therapeutics Ltd(ASX:PYC)?
Does PYC Therapeutics Ltd(ASX:PYC) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |